SCHEMBL19501136

SCHEMBL19501136

c1ccc(-c2cc(-c3ccccc3)nc(-c3cccc(-c4cccc(-c5cccc(-c6ccc7c8ccccc8c8ccccc8c7c6)c5)c4)c3)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.46
MEN1 O00255 5/20 0.45
KMT2A Q03164 5/20 0.45
RAB9A P51151 1/20 0.45
DHODH Q02127 1/20 0.44
ACHE P22303 1/20 0.42
MCL1 Q07820 2/20 0.42
ALDH1A1 P00352 3/20 0.41
HPGD P15428 3/20 0.41
KDM4E B2RXH2 2/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
GLA P06280 1/20 0.41
CTRC Q99895 1/20 0.41
MYC P01106 1/20 0.40
ADORA1 P30542 2/20 0.40
ADORA2A P29274 1/20 0.40
ALOX5 P09917 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19501128 1.00 CYP19A1 (0.46) CYP19A1MEN1KMT2ARAB9ADHODH
SCHEMBL19501134 1.00 CYP19A1 (0.46) CYP19A1MEN1KMT2ARAB9ADHODH
SCHEMBL25106116 1.00 CYP19A1 (0.46) CYP19A1MEN1KMT2ARAB9ADHODH
SCHEMBL26286214 1.00 CYP19A1 (0.46) CYP19A1MEN1KMT2ARAB9ADHODH
SCHEMBL19271351 0.98 CYP19A1 (0.47) CYP19A1MEN1KMT2ARAB9ADHODH
SCHEMBL16641437 0.98 CYP19A1 (0.47) CYP19A1MEN1KMT2ARAB9ADHODH
SCHEMBL21390684 0.98 CYP19A1 (0.47) CYP19A1MEN1KMT2ARAB9ADHODH
SCHEMBL18996703 0.98 CYP19A1 (0.47) CYP19A1MEN1KMT2ARAB9ADHODH
SCHEMBL16641389 0.96 MEN1 (0.48) CYP19A1MEN1KMT2ARAB9ADHODH
SCHEMBL16641413 0.96 MEN1 (0.48) CYP19A1MEN1KMT2ARAB9ADHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210013426-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2021-01-14 US disclosed
US-20170309831-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-10-26 US disclosed
US-20170309831-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210013426-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE OR10J3, OXER1, OR51E2 CYP19A1 701/4885MEN1 2720/4885KMT2A 4687/4885
US-20170309831-A1 COMPOSITION FOR ORGANIC OPTOELECTRIC DEVICE AND ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE OR10J3, OXER1, OR51E2 CYP19A1 701/4885MEN1 2720/4885KMT2A 4687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.